文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

单纯疱疹病毒1型易感性为脓毒症危险因素,巨细胞病毒易感性升高严重程度:双向孟德尔随机化研究

HERPES SIMPLEX VIRUS-1 SUSCEPTIBILITY AS A RISK FACTOR FOR SEPSIS, WITH CYTOMEGALOVIRUS SUSCEPTIBILITY ELEVATING SEVERITY: INSIGHTS FROM A BIDIRECTIONAL MENDELIAN RANDOMIZATION STUDY.
PubMed 文献 · Shock · 2024-03-25
一句话结论双向孟德尔随机化显示HSV-1易感性是脓毒症危险因素,CMV易感性升高脓毒症严重程度并增加28天死亡风险。

本研究采用两样本双向孟德尔随机化方法,利用公开全基因组关联研究数据,分析HSV-1、HSV-2、EBV和CMV四种疱疹病毒(以血清阳性和抗体水平为指标)与脓毒症的因果关系。正向MR显示HSV-1易感性是脓毒症危险因素;CMV易感性对脓毒症呈严重程度依赖性效应,是脓毒症28天死亡及重症监护入院28天脓毒症死亡的危险因素;EBV感染后EA-D抗体水平是重症监护入院28天脓毒症死亡的保护因素,CMV pp28抗体水平是危险因素;HSV-2与脓毒症无统计学显著因果关系。反向MR显示脓毒症重症监护入院组CMV pp52抗体水平下降。作者认为结果有助于预后和预测富集,为精准脓毒症治疗提供信息。

要点

  • 正向MR显示HSV-1易感性是脓毒症的危险因素。
  • CMV易感性对脓毒症呈严重程度依赖性效应,是脓毒症28天死亡及重症监护入院28天脓毒症死亡的危险因素。
  • EBV感染后EA-D抗体水平是重症监护入院28天脓毒症死亡的保护因素;CMV pp28抗体水平是重症监护入院28天脓毒症死亡的危险因素。
  • 反向MR显示脓毒症重症监护入院组CMV pp52抗体水平下降,提示严重脓毒症导致CMV抗体水平下降。
  • HSV-2与脓毒症之间未发现统计学显著的因果关系;未发现与脓毒症重症监护入院作为结局有统计学显著关联的暴露。

适用人群与场景

  • 研究对象为脓毒症患者,包括脓毒症28天死亡和重症监护入院28天脓毒症死亡人群;数据来自公开全基因组关联研究。

研究设计与关键结果

  • 研究设计为两样本双向孟德尔随机化研究,使用公开全基因组关联研究数据,选取HSV-1、HSV-2、EBV和CMV四种病毒,以血清阳性和血清抗体水平作为疱疹病毒数据。
  • 正向MR:HSV-1易感性是脓毒症的危险因素;CMV易感性对脓毒症呈严重程度依赖性效应,是脓毒症28天死亡的危险因素,也是重症监护入院28天脓毒症死亡的危险因素。
  • 正向MR:EBV感染后EA-D抗体水平是重症监护入院28天脓毒症死亡的保护因素;CMV pp28抗体水平是重症监护入院28天脓毒症死亡的危险因素。
  • 正向MR:HSV-2与脓毒症之间未发现统计学显著的因果关系;未发现与脓毒症重症监护入院作为结局有统计学显著关联的暴露。
  • 反向MR:脓毒症重症监护入院组CMV pp52抗体水平下降;脓毒症暴露与其他疱疹病毒结局之间未发现统计学显著的因果关系。

证据类型、等级与局限

  • 证据类型:两样本双向孟德尔随机化研究;原文未报告证据等级或推荐强度。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,本研究结果有助于预后和预测富集,并为精准脓毒症治疗提供有价值的信息。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Objective: We conducted a two-sample bidirectional Mendelian randomization (MR) study to investigate the causal relationships between herpes viruses and sepsis. Methods: Publicly available genome-wide association study data were used. Four viruses, HSV-1, HSV-2, EBV, and CMV, were selected, with serum positivity and levels of antibody in serum as the herpes virus data. Results: In forward MR, susceptibility to HSV-1 was a risk factor for sepsis. The susceptibility to CMV showed a severity-dependent effect on sepsis and was a risk factor for the 28-day mortality from sepsis, and was also a risk factor for 28-day sepsis mortality in critical care admission. The EBV EA-D antibody level after EBV infection was a protective factor for 28-day sepsis mortality in critical care admission, and CMV pp28 antibody level was a risk factor for 28-day sepsis mortality in critical care admission. No statistically significant causal relationships between HSV-2 and sepsis were found. No exposures having statistically significant association with sepsis critical care admission as an outcome were found. In reverse MR, the sepsis critical care admission group manifested a decrease in CMV pp52 antibody levels. No causal relationships with statistical significance between sepsis exposure and other herpes virus outcomes were found. Conclusion: Our study identifies HSV-1 susceptibility as a sepsis risk, with CMV susceptibility elevating severity. Varied effects of EBV and CMV antibodies on sepsis severity are noted. Severe sepsis results in a decline in CMV antibody levels. Our results help prognostic and predictive enrichment and offer valuable information for precision sepsis treatment.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Shi W, Lin Q, Zhang M, et al. HERPES SIMPLEX VIRUS-1 SUSCEPTIBILITY AS A RISK FACTOR FOR SEPSIS, WITH CYTOMEGALOVIRUS SUSCEPTIBILITY ELEVATING SEVERITY: INSIGHTS FROM A BIDIRECTIONAL MENDELIAN RANDOMIZATION STUDY. Shock. 2024. PMID: 38662585. doi:10.1097/SHK.0000000000002351

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。